Greenwich LifeSciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $9,327,866.
Profit Margin
| 2017 | 0 | -1.57M | |
|---|---|---|---|
| 2018 | 0 | -1.68M | |
| 2019 | 0 | -3.42M | |
| 2020 | 0 | -1.86M | |
| 2021 | 0 | -4.54M | |
| 2022 | 0 | -7.61M | |
| 2023 | 0 | -8.89M |
GLSI Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 3.61K | 3.61K | 3.61K | 3.60K | 3.60K | 0 | 3.60K |
Gross profit | -3.61K | -3.61K | -3.61K | -3.60K | -3.60K | 0 | -3.60K |
Operating exp. | |||||||
Research and development | 7.69M | 6.47M | 3.55M | 1.05M | 2.60M | 1.27M | 1.22M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 9.32M | 8.04M | 4.59M | 1.86M | 3.42M | 1.68M | 1.56M |
Operating income | -9.32M | -8.04M | -4.59M | -1.86M | -3.42M | -1.68M | -1.57M |
Other income (expenses), net | 436.06K | 215.01K | 27.36K | 832 | 3 | 0 | 0 |
Income before tax | -8.89M | -7.82M | -4.57M | -1.86M | -3.42M | -1.68M | -1.57M |
Income tax expense | 0 | -215.01K | -27.36K | -832 | 3 | 0 | 3 |
Net income | -8.89M | -7.61M | -4.54M | -1.86M | -3.42M | -1.68M | -1.57M |
Earnings per share | |||||||
Basic EPS | -0.69 | -0.59 | -0.35 | -0.15 | -0.29 | -0.14 | -0.13 |
Diluted EPS | -0.69 | -0.59 | -0.35 | -0.15 | -0.29 | -0.14 | -0.13 |
| Data source | Data source | Data source | Data source |